List of Tables
    Table 1. Global Recombinant Coagulation Factor Concentrate Sales Growth Rate Comparison by Dose (2022-2028) & (K Units) & (US$ Million)
    Table 2. Global Recombinant Coagulation Factor Concentrate Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
    Table 3. Global Recombinant Coagulation Factor Concentrate Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global Recombinant Coagulation Factor Concentrate Market Competitive Situation by Manufacturers in 2021
    Table 5. Global Recombinant Coagulation Factor Concentrate Sales (K Units) of Key Manufacturers (2017-2022)
    Table 6. Global Recombinant Coagulation Factor Concentrate Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global Recombinant Coagulation Factor Concentrate Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global Recombinant Coagulation Factor Concentrate Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market Recombinant Coagulation Factor Concentrate Average Price (US$/Unit) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers Recombinant Coagulation Factor Concentrate Manufacturing Sites and Area Served
    Table 11. Manufacturers Recombinant Coagulation Factor Concentrate Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Recombinant Coagulation Factor Concentrate by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant Coagulation Factor Concentrate as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Recombinant Coagulation Factor Concentrate Sales by Region (2017-2022) & (K Units)
    Table 16. Global Recombinant Coagulation Factor Concentrate Sales Market Share by Region (2017-2022)
    Table 17. Global Recombinant Coagulation Factor Concentrate Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global Recombinant Coagulation Factor Concentrate Revenue Market Share by Region (2017-2022)
    Table 19. North America Recombinant Coagulation Factor Concentrate Sales by Country (2017-2022) & (K Units)
    Table 20. North America Recombinant Coagulation Factor Concentrate Sales Market Share by Country (2017-2022)
    Table 21. North America Recombinant Coagulation Factor Concentrate Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America Recombinant Coagulation Factor Concentrate Revenue Market Share by Country (2017-2022)
    Table 23. Europe Recombinant Coagulation Factor Concentrate Sales by Country (2017-2022) & (K Units)
    Table 24. Europe Recombinant Coagulation Factor Concentrate Sales Market Share by Country (2017-2022)
    Table 25. Europe Recombinant Coagulation Factor Concentrate Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe Recombinant Coagulation Factor Concentrate Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific Recombinant Coagulation Factor Concentrate Sales by Region (2017-2022) & (K Units)
    Table 28. Asia Pacific Recombinant Coagulation Factor Concentrate Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific Recombinant Coagulation Factor Concentrate Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific Recombinant Coagulation Factor Concentrate Revenue Market Share by Region (2017-2022)
    Table 31. Latin America Recombinant Coagulation Factor Concentrate Sales by Country (2017-2022) & (K Units)
    Table 32. Latin America Recombinant Coagulation Factor Concentrate Sales Market Share by Country (2017-2022)
    Table 33. Latin America Recombinant Coagulation Factor Concentrate Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America Recombinant Coagulation Factor Concentrate Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa Recombinant Coagulation Factor Concentrate Sales by Country (2017-2022) & (K Units)
    Table 36. Middle East and Africa Recombinant Coagulation Factor Concentrate Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa Recombinant Coagulation Factor Concentrate Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa Recombinant Coagulation Factor Concentrate Revenue Market Share by Country (2017-2022)
    Table 39. Global Recombinant Coagulation Factor Concentrate Sales by Dose (2017-2022) & (K Units)
    Table 40. Global Recombinant Coagulation Factor Concentrate Sales Market Share by Dose (2017-2022)
    Table 41. Global Recombinant Coagulation Factor Concentrate Revenue by Dose (2017-2022) & (US$ Million)
    Table 42. Global Recombinant Coagulation Factor Concentrate Revenue Share by Dose (2017-2022)
    Table 43. Global Recombinant Coagulation Factor Concentrate Price by Dose (2017-2022) & (US$/Unit)
    Table 44. Global Recombinant Coagulation Factor Concentrate Sales (K Units) by Application (2017-2022)
    Table 45. Global Recombinant Coagulation Factor Concentrate Sales Market Share by Application (2017-2022)
    Table 46. Global Recombinant Coagulation Factor Concentrate Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global Recombinant Coagulation Factor Concentrate Revenue Share by Application (2017-2022)
    Table 48. Global Recombinant Coagulation Factor Concentrate Price by Application (2017-2022) & (US$/Unit)
    Table 49. Bayer Corporation Information
    Table 50. Bayer Description and Business Overview
    Table 51. Bayer Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 52. Bayer Recombinant Coagulation Factor Concentrate Product
    Table 53. Bayer Recent Developments/Updates
    Table 54. Alprolix Corporation Information
    Table 55. Alprolix Description and Business Overview
    Table 56. Alprolix Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 57. Alprolix Recombinant Coagulation Factor Concentrate Product
    Table 58. Alprolix Recent Developments/Updates
    Table 59. Benefix Corporation Information
    Table 60. Benefix Description and Business Overview
    Table 61. Benefix Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 62. Benefix Recombinant Coagulation Factor Concentrate Product
    Table 63. Benefix Recent Developments/Updates
    Table 64. Idelvion Corporation Information
    Table 65. Idelvion Description and Business Overview
    Table 66. Idelvion Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 67. Idelvion Recombinant Coagulation Factor Concentrate Product
    Table 68. Idelvion Recent Developments/Updates
    Table 69. Lxinity Corporation Information
    Table 70. Lxinity Description and Business Overview
    Table 71. Lxinity Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 72. Lxinity Recombinant Coagulation Factor Concentrate Product
    Table 73. Lxinity Recent Developments/Updates
    Table 74. Rebinyn Corporation Information
    Table 75. Rebinyn Description and Business Overview
    Table 76. Rebinyn Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 77. Rebinyn Recombinant Coagulation Factor Concentrate Product
    Table 78. Rebinyn Recent Developments/Updates
    Table 79. Rixubis Corporation Information
    Table 80. Rixubis Description and Business Overview
    Table 81. Rixubis Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 82. Rixubis Recombinant Coagulation Factor Concentrate Product
    Table 83. Rixubis Recent Developments/Updates
    Table 84. CSL Corporation Information
    Table 85. CSL Description and Business Overview
    Table 86. CSL Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 87. CSL Recombinant Coagulation Factor Concentrate Product
    Table 88. CSL Recent Developments/Updates
    Table 89. Baxalta Corporation Information
    Table 90. Baxalta Description and Business Overview
    Table 91. Baxalta Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 92. Baxalta Recombinant Coagulation Factor Concentrate Product
    Table 93. Baxalta Recent Developments/Updates
    Table 94. Sanofi Corporation Information
    Table 95. Sanofi Description and Business Overview
    Table 96. Sanofi Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 97. Sanofi Recombinant Coagulation Factor Concentrate Product
    Table 98. Sanofi Recent Developments/Updates
    Table 99. Biogen Corporation Information
    Table 100. Biogen Description and Business Overview
    Table 101. Biogen Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 102. Biogen Recombinant Coagulation Factor Concentrate Product
    Table 103. Biogen Recent Developments/Updates
    Table 104. Pfizer Corporation Information
    Table 105. Pfizer Description and Business Overview
    Table 106. Pfizer Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 107. Pfizer Recombinant Coagulation Factor Concentrate Product
    Table 108. Pfizer Recent Developments/Updates
    Table 109. Novo Disk Corporation Information
    Table 110. Novo Disk Description and Business Overview
    Table 111. Novo Disk Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 112. Novo Disk Recombinant Coagulation Factor Concentrate Product
    Table 113. Novo Disk Recent Developments/Updates
    Table 114. Baxter Corporation Information
    Table 115. Baxter Description and Business Overview
    Table 116. Baxter Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 117. Baxter Recombinant Coagulation Factor Concentrate Product
    Table 118. Baxter Recent Developments/Updates
    Table 119. Wyeth Corporation Information
    Table 120. Wyeth Description and Business Overview
    Table 121. Wyeth Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 122. Wyeth Recombinant Coagulation Factor Concentrate Product
    Table 123. Wyeth Recent Developments/Updates
    Table 124. 北京天坛生物制品股份有限公司 Corporation Information
    Table 125. 北京天坛生物制品股份有限公司 Description and Business Overview
    Table 126. 北京天坛生物制品股份有限公司 Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 127. 北京天坛生物制品股份有限公司 Recombinant Coagulation Factor Concentrate Product
    Table 128. 北京天坛生物制品股份有限公司 Recent Developments/Updates
    Table 129. 上海莱士 Corporation Information
    Table 130. 上海莱士 Description and Business Overview
    Table 131. 上海莱士 Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 132. 上海莱士 Recombinant Coagulation Factor Concentrate Product
    Table 133. 上海莱士 Recent Developments/Updates
    Table 134. 泰邦生物 Corporation Information
    Table 135. 泰邦生物 Description and Business Overview
    Table 136. 泰邦生物 Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 137. 泰邦生物 Recombinant Coagulation Factor Concentrate Product
    Table 138. 泰邦生物 Recent Developments/Updates
    Table 139. 华兰生物 Corporation Information
    Table 140. 华兰生物 Description and Business Overview
    Table 141. 华兰生物 Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 142. 华兰生物 Recombinant Coagulation Factor Concentrate Product
    Table 143. 华兰生物 Recent Developments/Updates
    Table 144. 绿十字（中国）生物制品有限公司 Corporation Information
    Table 145. 绿十字（中国）生物制品有限公司 Description and Business Overview
    Table 146. 绿十字（中国）生物制品有限公司 Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 147. 绿十字（中国）生物制品有限公司 Recombinant Coagulation Factor Concentrate Product
    Table 148. 绿十字（中国）生物制品有限公司 Recent Developments/Updates
    Table 149. Production Base and Market Concentration Rate of Raw Material
    Table 150. Key Suppliers of Raw Materials
    Table 151. Recombinant Coagulation Factor Concentrate Distributors List
    Table 152. Recombinant Coagulation Factor Concentrate Customers List
    Table 153. Recombinant Coagulation Factor Concentrate Market Trends
    Table 154. Recombinant Coagulation Factor Concentrate Market Drivers
    Table 155. Recombinant Coagulation Factor Concentrate Market Challenges
    Table 156. Recombinant Coagulation Factor Concentrate Market Restraints
    Table 157. Global Recombinant Coagulation Factor Concentrate Sales Forecast by Dose (2023-2028) & (K Units)
    Table 158. Global Recombinant Coagulation Factor Concentrate Sales Market Share Forecast by Dose (2023-2028)
    Table 159. Global Recombinant Coagulation Factor Concentrate Revenue Forecast by Dose (2023-2028) & (US$ Million)
    Table 160. Global Recombinant Coagulation Factor Concentrate Revenue Market Share Forecast by Dose (2023-2028)
    Table 161. Global Recombinant Coagulation Factor Concentrate Sales Forecast by Application (2023-2028) & (K Units)
    Table 162. Global Recombinant Coagulation Factor Concentrate Sales Market Share Forecast by Application (2023-2028)
    Table 163. Global Recombinant Coagulation Factor Concentrate Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 164. Global Recombinant Coagulation Factor Concentrate Revenue Market Share Forecast by Application (2023-2028)
    Table 165. Global Recombinant Coagulation Factor Concentrate Sales Forecast by Region (2023-2028) & (K Units)
    Table 166. Global Recombinant Coagulation Factor Concentrate Sales Market Share Forecast by Region (2023-2028)
    Table 167. Global Recombinant Coagulation Factor Concentrate Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 168. Global Recombinant Coagulation Factor Concentrate Revenue Market Share Forecast by Region (2023-2028)
    Table 169. Research Programs/Design for This Report
    Table 170. Key Data Information from Secondary Sources
    Table 171. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Recombinant Coagulation Factor Concentrate
    Figure 2. Global Recombinant Coagulation Factor Concentrate Market Share by Dose in 2021 & 2028
    Figure 3. 250 IU Product Picture
    Figure 4. 500 IU Product Picture
    Figure 5. 1000 IU Product Picture
    Figure 6. 2000 IU Product Picture
    Figure 7. Global Recombinant Coagulation Factor Concentrate Market Share by Application in 2021 & 2028
    Figure 8. Hopistial
    Figure 9. Clinic
    Figure 10. Others
    Figure 11. Global Recombinant Coagulation Factor Concentrate Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Recombinant Coagulation Factor Concentrate Market Size (2017-2028) & (US$ Million)
    Figure 13. Global Recombinant Coagulation Factor Concentrate Sales (2017-2028) & (K Units)
    Figure 14. Recombinant Coagulation Factor Concentrate Sales Share by Manufacturers in 2021
    Figure 15. Global Recombinant Coagulation Factor Concentrate Revenue Share by Manufacturers in 2021
    Figure 16. The Global 5 and 10 Largest Recombinant Coagulation Factor Concentrate Players: Market Share by Revenue in 2021
    Figure 17. Recombinant Coagulation Factor Concentrate Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 18. Global Recombinant Coagulation Factor Concentrate Sales Market Share by Region (2017-2022)
    Figure 19. Global Recombinant Coagulation Factor Concentrate Sales Market Share by Region in 2021
    Figure 20. Global Recombinant Coagulation Factor Concentrate Revenue Market Share by Region (2017-2022)
    Figure 21. Global Recombinant Coagulation Factor Concentrate Revenue Market Share by Region in 2021
    Figure 22. United States Recombinant Coagulation Factor Concentrate Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 23. Canada Recombinant Coagulation Factor Concentrate Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 24. Germany Recombinant Coagulation Factor Concentrate Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 25. France Recombinant Coagulation Factor Concentrate Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 26. U.K. Recombinant Coagulation Factor Concentrate Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 27. Italy Recombinant Coagulation Factor Concentrate Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 28. Russia Recombinant Coagulation Factor Concentrate Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. China Recombinant Coagulation Factor Concentrate Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. Japan Recombinant Coagulation Factor Concentrate Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. South Korea Recombinant Coagulation Factor Concentrate Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. India Recombinant Coagulation Factor Concentrate Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. Australia Recombinant Coagulation Factor Concentrate Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. China Taiwan Recombinant Coagulation Factor Concentrate Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. Indonesia Recombinant Coagulation Factor Concentrate Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. Thailand Recombinant Coagulation Factor Concentrate Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. Malaysia Recombinant Coagulation Factor Concentrate Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. Mexico Recombinant Coagulation Factor Concentrate Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 39. Brazil Recombinant Coagulation Factor Concentrate Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 40. Argentina Recombinant Coagulation Factor Concentrate Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 41. Turkey Recombinant Coagulation Factor Concentrate Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 42. Saudi Arabia Recombinant Coagulation Factor Concentrate Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 43. UAE Recombinant Coagulation Factor Concentrate Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 44. Sales Market Share of Recombinant Coagulation Factor Concentrate by Dose (2017-2022)
    Figure 45. Manufacturing Cost Structure of Recombinant Coagulation Factor Concentrate
    Figure 46. Manufacturing Process Analysis of Recombinant Coagulation Factor Concentrate
    Figure 47. Recombinant Coagulation Factor Concentrate Industrial Chain Analysis
    Figure 48. Channels of Distribution
    Figure 49. Distributors Profiles
    Figure 50. Bottom-up and Top-down Approaches for This Report
    Figure 51. Data Triangulation
    Figure 52. Key Executives Interviewed